Anavex Life Sciences Corp. (AVXL)
3.105
-0.14
(-4.17%)
USD |
NASDAQ |
Aug 24, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Shareholders Equity (Quarterly) : 121.71M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 121.71M |
| December 31, 2025 | 126.62M |
| September 30, 2025 | 94.87M |
| June 30, 2025 | 90.96M |
| March 31, 2025 | 99.76M |
| December 31, 2024 | 110.92M |
| September 30, 2024 | 120.26M |
| June 30, 2024 | 129.87M |
| March 31, 2024 | 135.19M |
| December 31, 2023 | 135.58M |
| September 30, 2023 | 141.85M |
| June 30, 2023 | 146.75M |
| March 31, 2023 | 145.17M |
| December 31, 2022 | 135.12M |
| September 30, 2022 | 142.49M |
| June 30, 2022 | 150.74M |
| March 31, 2022 | 152.20M |
| December 31, 2021 | 146.37M |
| September 30, 2021 | 150.82M |
| June 30, 2021 | 157.15M |
| March 31, 2021 | 75.81M |
| December 31, 2020 | 46.30M |
| September 30, 2020 | 27.24M |
| June 30, 2020 | 24.68M |
| March 31, 2020 | 24.79M |
| Date | Value |
|---|---|
| December 31, 2019 | 25.96M |
| September 30, 2019 | 20.29M |
| June 30, 2019 | 17.63M |
| March 31, 2019 | 14.47M |
| December 31, 2018 | 17.22M |
| September 30, 2018 | 20.49M |
| June 30, 2018 | 23.59M |
| March 31, 2018 | 22.48M |
| December 31, 2017 | 25.55M |
| September 30, 2017 | 24.25M |
| June 30, 2017 | 23.45M |
| March 31, 2017 | 21.49M |
| December 31, 2016 | 19.18M |
| September 30, 2016 | 6.308M |
| June 30, 2016 | 7.671M |
| March 31, 2016 | 9.683M |
| December 31, 2015 | 11.49M |
| September 30, 2015 | 12.81M |
| June 30, 2015 | 6.569M |
| March 31, 2015 | 4.702M |
| December 31, 2014 | 0.4731M |
| September 30, 2014 | 0.1926M |
| June 30, 2014 | 7.409M |
| March 31, 2014 | 8.408M |
| December 31, 2013 | -1.670M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 69.41M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.77M |
| Total Liabilities (Quarterly) | 7.059M |
| Current Ratio | 18.24 |